Health Care Innovation & Non-Traditional Care with Shivan Mehta, MD

In this podcast episode, Shivan Mehta, MD, MBA, MSHP, discusses behavioral economics in patients and clinicians, the entrance of non-traditional entities in the health care space and more.

• Intro :02
• Welcome to this episode of Gut Talk :23
• The interview/about Mehta :30
• How did you get to where you are now? What got you interested in medicine, and how did you end up with the role that you have today? :58
• Can you elaborate more on the people who had an influence on you? 3:10
• About behavioral economics 5:39
• Are there tried and true theories in behavioral economics around what works to change patient behavior? 9:25
• What about insurance companies with steerage? … Are there studies that show that those are different types of financial incentives, as opposed to paying someone? 15:45
• Have we seen, or is there research on the effect of, pricing something lower in patients’ decision making in health care? 19:25
• As an academic researcher and administrator, what do you think about the entrance of non-traditional entities in health care compared to the work that is being done by clinicians and at academic centers? 22:03
• Do you see the move from fee-for-service to quality care happening? 26:41
• Thoughts on the future of funding in health care 28:38
• What do you think about the physician’s role in current and future innovation? 31:32
• How do we create a generation of physicians who are thinking more innovatively and entrepreneurially? 34:51
• Thank you, Dr. Mehta 41:43
• Thanks for listening 41:50

Shivan Mehta, MD, MBA, MSHP, is associate chief innovation officer at Penn Medicine and associate professor of Medicine and Health Policy at the Perelman School of Medicine.

We’d love to hear from you! Send your comments/questions to [e-mail]. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc. For more from Dr. Mehta, follow @Shivan_Mehtaon Twitter.

Disclosures: Chey and Berry report no relevant financial disclosures. Mehta serves on a clinical advisory board for Guardant Health and receives grant funding from the National Institutes of Health.